Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.49
-0.62 (-6.13%)
At close: Mar 3, 2026, 4:00 PM EST
9.49
0.00 (-0.04%)
After-hours: Mar 3, 2026, 7:59 PM EST
Novavax Stock Forecast
Stock Price Forecast
The 9 analysts that cover Novavax stock have a consensus rating of "Hold" and an average price target of $11.33, which forecasts a 19.39% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $19.
Price Target: $11.33 (+19.39%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novavax stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 6 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $16 | Strong Buy | Maintains | $11 → $16 | +68.60% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +100.21% | Jan 20, 2026 |
| JP Morgan | JP Morgan | Sell Maintains $7 → $6 | Sell | Maintains | $7 → $6 | -36.78% | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $18 → $16 | Strong Buy | Reiterates | $18 → $16 | +68.60% | Nov 10, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -26.24% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
388.85M
from 1.12B
Decreased by -65.39%
Revenue Next Year
274.58M
from 388.85M
Decreased by -29.39%
EPS This Year
-0.32
from 2.58
EPS Next Year
0.10
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 592.5M | 482.6M | |||
| Avg | 388.9M | 274.6M | |||
| Low | 244.7M | 138.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -47.3% | 24.1% | |||
| Avg | -65.4% | -29.4% | |||
| Low | -78.2% | -64.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.41 | 1.52 | |||
| Avg | -0.32 | 0.10 | |||
| Low | -0.92 | -0.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -84.1% | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.